Requirement of argininosuccinate lyase for systemic nitric oxide production

Nature Medicine

Volumn 17, Issue 12, 2011, Pages 1619-1626

  Erez, Ayelet ^a   Nagamani, Sandesh C S ^a   Shchelochkov, Oleg A ^a   Premkumar, Muralidhar H ^a   Campeau, Philippe M ^a   Chen, Yuqing ^a,b   Garg, Harsha K ^c   Li, Li ^d   Mian, Asad ^a   Bertin, Terry K ^a,b   Black, Jennifer O ^e   Zeng, Heng ^f   Tang, Yaoping ^c   Reddy, Anilkumar K ^a,g   Summar, Marshall ^f   O'Brien, William E ^a   Harrison, David G ^d   Mitch, William E ^a   Marini, Juan C ^a   Aschner, Judy L ^f   Bryan, Nathan S ^c   Lee, Brendan ^a,b   more..

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e TEXAS CHILDREN S HOSPITAL   (United States)

^f VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; ARGININE; ARGININOSUCCINATE LYASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MULTIPROTEIN COMPLEX; NEOMYCIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; UREA;

AMINO ACID ANALYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR SYSTEM; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SYNTHESIS; HISTOLOGY; HUMAN; HUMAN CELL; IN VIVO STUDY; INTRON; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UREA CYCLE;

ANIMALS; ARGININE; ARGININOSUCCINATE LYASE; ARGININOSUCCINATE SYNTHASE; ARGININOSUCCINIC ACIDURIA; CELL LINE; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FEMALE; FIBROBLASTS; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITES; RNA, SMALL INTERFERING; SEQUENCE ANALYSIS, DNA; SWINE;

MUS;

EID: 84856100270     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2544     Document Type: Article

References (37)

1. Flam B.R., Hartmann P.J., Harrell-Booth M., Solomonson L.P. & Eichler D.C. Caveolar localization of arginine regeneration enzymes, argininosuccinate synthase, and lyase, with endothelial nitric oxide synthase. Nitric Oxide 5, 187-197 (2001). (Pubitemid 34142742)
2. Mori M. & Gotoh T. Arginine metabolic enzymes, nitric oxide and infection. J. Nutr. 134, 2820S-2825S (2004). (Pubitemid 39315229)
3. Morris S.M. Jr. Arginine metabolism: Boundaries of our knowledge. J. Nutr. 137, 1602S-1609S (2007). (Pubitemid 46855518)
4. Krivitzky L. et al. Intellectual, adaptive and behavioral functioning in children with urea cycle disorders. Pediatr. Res. 66, 96-101 (2009).
5. Scaglia F. et al. Clinical consequences of urea cycle enzyme deficiencies and potential links to arginine and nitric oxide metabolism. J. Nutr. 134, 2775S-2782S (2004). (Pubitemid 39315220)
6. Zimmermann A., Bachmann C. & Baumgartner R. Severe liver fibrosis in argininosuccinic aciduria. Arch. Pathol. Lab. Med. 110, 136-140 (1986). (Pubitemid 16141851)
7. Mori T. et al. Progressive liver fibrosis in late-onset argininosuccinate lyase deficiency. Pediatr. Dev. Pathol. 5, 597-601 (2002). (Pubitemid 36188410)
8. Erez A., Nagamani S.C. & Lee B. Argininosuccinate lyase deficiency-argininosuccinic aciduria and beyond. Am. J. Med. Genet. C. Semin. Med. Genet. 157, 45-53 (2011).
9. Brunetti-Pierri N., Erez A., Shchelochkov O., Craigen W. & Lee B. Systemic hypertension in two patients with ASL deficiency: A result of nitric oxide deficiency? Mol. Genet. Metab. 98, 195-197 (2009).
10. Fakler C.R., Kaftan H.A. & Nelin L.D. Two cases suggesting a role for the l-arginine nitric oxide pathway in neonatal blood pressure regulation. Acta Paediatr. 84, 460-462 (1995).
11. Pearson D.L. et al. Neonatal pulmonary hypertension-urea-cycle intermediates, nitric oxide production and carbamoyl-phosphate synthetase function. N. Engl. J. Med. 344, 1832-1838 (2001). (Pubitemid 32538696)
12. Summar M.L. et al. Relationship between carbamoyl-phosphate synthetase genotype and systemic vascular function. Hypertension 43, 186-191 (2004). (Pubitemid 38174172)
13. Nagasaka H. et al. Evaluation of endogenous nitric oxide synthesis in congenital urea cycle enzyme defects. Metabolism 58, 278-282 (2009).
14. Reid Sutton V.P.Y., Davis E.C. & Craigen W.J. A mouse model of argininosuccinic aciduria: Biochemical characterization. Mol. Genet. Metab. 78, 11-16 (2003). (Pubitemid 36268737)
15. de Jonge W.J. et al. Overexpression of arginase I in enterocytes of transgenic mice elicits a selective arginine deficiency and affects skin, muscle and lymphoid development. Am. J. Clin. Nutr. 76, 128-140 (2002). (Pubitemid 34686558)
16. Auron A. & Brophy P.D. Hyperammonemia in review: Pathophysiology, diagnosis and treatment. Pediatr. Nephrol. published online, doi:10.1007/s00467-011-1838-5 (23 March 2011).
17. Naseem K.M. The role of nitric oxide in cardiovascular diseases. Mol. Aspects Med. 26, 33-65 (2005). (Pubitemid 40250164)
18. Tojo A.O.M. & Fujita T. Role of macula densa neuronal nitric oxide synthase in renal diseases. Med. Mol. Morphol. 39, 2-7 (2006). (Pubitemid 44306503)
19. Zweier J.L., Wang P., Samouilov A. & Kuppusamy P. Enzyme-independent formation of nitric oxide in biological tissues. Nat. Med. 1, 804-809 (1995).
20. Cosby K. et al. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat. Med. 9, 1498-1505 (2003). (Pubitemid 38004777)
21. Thomas G., Hecker M. & Ramwell P.W. Vascular activity of polycations and basic amino acids: L-arginine does not specifically elicit endothelium-dependent relaxation. Biochem. Biophys. Res. Commun. 158, 177-180 (1989). (Pubitemid 19045061)
22. Gold M.E., Wood K.S., Byrns R.E., Buga G.M. & Ignarro L.J. l-arginine-dependent vascular smooth muscle relaxation and cGMP formation. Am. J. Physiol. 259, H1813-H1821 (1990).
23. Bode-Böger S.M., Scalera F. & Ignarro L.J. The l-arginine paradox: Importance of the l-arginine/asymmetrical dimethylarginine ratio. Pharmacol. Ther. 114, 295-306 (2007). (Pubitemid 46843253)
24. Cals-Grierson M.M. & Ormerod A.D. Nitric oxide function in the skin. Nitric Oxide 10, 179-193 (2004). (Pubitemid 38953389)
25. Shimizu Y., Sakai M., Umemura Y. & Ueda H. Immunohistochemical localization of nitric oxide synthase in normal human skin: Expression of endothelial-type and inducible-type nitric oxide synthase in keratinocytes. J. Dermatol. 24, 80-87 (1997). (Pubitemid 27150187)
26. Wang R., Ghahary A., Shen Y.J., Scott P.G. & Tredget E.E. Human dermal fibroblasts produce nitric oxide and express both constitutive and inducible nitric oxide synthase isoforms. J. Invest. Dermatol. 106, 419-427 (1996). (Pubitemid 26116485)
27. Kurotobi S. et al. Impaired vascular endothelium-dependent relaxation in Henoch-Schonlein purpura. Pediatr. Nephrol. 19, 138-143 (2004). (Pubitemid 38181003)
28. Flam B.R., Hartmann P.J., Harrell-Booth M., Solomonson L.P. & Eichler D.C. Caveolar localization of arginine regeneration enzymes, argininosuccinate synthase, and lyase, with endothelial nitric oxide synthase. Nitric Oxide 5, 187-197 (2001). (Pubitemid 34142742)
29. Solomonson L.P., Flam B.R., Pendleton L.C., Goodwin B.L. & Eichler D.C. The caveolar nitric oxide synthase/arginine regeneration system for NO production in endothelial cells. J. Exp. Biol. 206, 2083-2087 (2003). (Pubitemid 36761811)
30. Oyadomari S. et al. Coinduction of endothelial nitric oxide synthase and arginine recycling enzymes in aorta of diabetic rats. Nitric Oxide 5, 252-260 (2001). (Pubitemid 32553596)
31. Li C., Huang W., Harris M.B., Goolsby J.M. & Venema R.C. Interaction of the endothelial nitric oxide synthase with the CAT-1 arginine transporter enhances NO release by a mechanism not involving arginine transport. Biochem. J. 386, 567-574 (2005). (Pubitemid 40445882)
32. Trevisson E. et al. Functional complementation in yeast allows molecular characterization of missense argininosuccinate lyase mutations. J. Biol. Chem. 284, 28926-28934 (2009).
33. Trevisson E. et al. Argininosuccinate lyase deficiency: Mutational spectrum in Italian patients and identification of a novel ASL pseudogene. Hum. Mutat. 28, 694-702 (2007). (Pubitemid 47047296)
34. Trevisson E. et al. Functional complementation in yeast allows molecular characterization of missense argininosuccinate lyase mutations. J. Biol. Chem. 284, 28926-28934 (2009).
35. Trevisson E. et al. Argininosuccinate lyase deficiency: Mutational spectrum in Italian patients and identification of a novel ASL pseudogene. Hum. Mutat. 28, 694-702 (2007). (Pubitemid 47047296)
36. Vallee F., Turner M.A., Lindley P.L. & Howell P.L. Crystal structure of an inactive duck delta II crystallin mutant with bound argininosuccinate. Biochemistry 38, 2425-2434 (1999).
37. Lee H.J., Chiou S.H. & Chang G.G. Biochemical characterization and kinetic analysis of duck delta-crystallin with endogenous argininosuccinate lyase activity. Biochem. J. 283, 597-603 (1992).